Help ?

IGMIN: We're glad you're here. Please click 'create a new query' if you are a new visitor to our website and need further information from us.

If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click 'take me to my Query.'

Subjects/Topics

Welcome to IgMin Research – an Open Access journal uniting Biology Group, Medicine Group, and Engineering Group. We’re dedicated to advancing global knowledge and fostering collaboration across scientific fields.

Members

Our vision is to catalyze cross-disciplinary ideas that drive rapid advancements in knowledge.

Articles

Our vision is to catalyze cross-disciplinary ideas that drive rapid advancements in knowledge.

Explore Content

Our vision is to catalyze cross-disciplinary ideas that drive rapid advancements in knowledge.

Identify Us

Our vision is to catalyze cross-disciplinary ideas that drive rapid advancements in knowledge.

IgMin Corporation

Welcome to IgMin, a leading platform dedicated to enhancing knowledge dissemination and professional growth across multiple fields of science, technology, and the humanities. We believe in the power of open access, collaboration, and innovation. Our goal is to provide individuals and organizations with the tools they need to succeed in the global knowledge economy.

Publications Support
[email protected]
E-Books Support
[email protected]
Webinars & Conferences Support
[email protected]
Content Writing Support
[email protected]
IT Support
[email protected]

Search

Explore Section

Content for the explore section slider goes here.

Abstract

Abstract at IgMin Research

Our vision is to catalyze cross-disciplinary ideas that drive rapid advancements in knowledge.

Medicine Group Editorial Article ID: igmin268

The Intersection of Artificial Intelligence in Public Health and Personalized Cancer Therapy

Obstetrics & Gynecology DOI10.61927/igmin268 Affiliation

Affiliation

    Mudasir Rashid, Department of Medicine and Cancer Center, Howard University Hospital, Washington DC, USA, Email: [email protected]

209
VIEWS
98
DOWNLOADS
Connect with Us

Abstract

This editorial aims to highlight the critical intersections of patient care and technology, as illustrated in our recent article collection and addresses urgent challenges posed by global health crises like the COVID-19 pandemic while exploring broader themes such as personalized medicine, ethical practices, and the nutritional impacts on health. This diverse range of research highlights the necessity of interdisciplinary approaches to address the complexities of modern healthcare.

Figures

References

    1. Mario C. Country risk to face global emergencies: negative effects of high public debt on health expenditures and fatality rate in COVID-19 pandemic crisis. IgMin Res. 2024;2:537-45.
    2. Shakibfar S, Nyberg F, Li H, Zhao J, Nordeng HME, Sandve GKF, Pavlovic M, Hajiebrahimi M, Andersen M, Sessa M. Artificial intelligence-driven prediction of COVID-19-related hospitalization and death: a systematic review. Front Public Health. 2023 Jun 20;11:1183725. doi: 10.3389/fpubh.2023.1183725. PMID: 37408750; PMCID: PMC10319067.
    3. Hasan MM, Islam MU, Sadeq MJ, Fung WK, Uddin J. Review on the Evaluation and Development of Artificial Intelligence for COVID-19 Containment. Sensors (Basel). 2023 Jan 3;23(1):527. doi: 10.3390/s23010527. PMID: 36617124; PMCID: PMC9824505.
    4. Ahmadi Marzaleh M, Peyravi M, Mousavi S, Sarpourian F, Seyedi M, Shalyari N. Artificial Intelligence Functionalities During the COVID-19 Pandemic. Disaster Med Public Health Prep. 2023 Feb 27;17:e336. doi: 10.1017/dmp.2023.3. PMID: 36847255.
    5. Farhat F, Sohail SS, Alam MT, Ubaid S, Shakil, Ashhad M, Madsen DØ. COVID-19 and beyond: leveraging artificial intelligence for enhanced outbreak control. Front Artif Intell. 2023 Nov 8;6:1266560. doi: 10.3389/frai.2023.1266560. PMID: 38028660; PMCID: PMC10663297.
    6. Khan M, Mehran MT, Haq ZU, Ullah Z, Naqvi SR, Ihsan M, Abbass H. Applications of artificial intelligence in COVID-19 pandemic: A comprehensive review. Expert Syst Appl. 2021 Dec 15;185:115695. doi: 10.1016/j.eswa.2021.115695. Epub 2021 Aug 4. PMID: 34400854; PMCID: PMC8359727.
    7. Wang L, Zhang Y, Wang D, Tong X, Liu T, Zhang S, Huang J, Zhang L, Chen L, Fan H, Clarke M. Artificial Intelligence for COVID-19: A Systematic Review. Front Med (Lausanne). 2021 Sep 30;8:704256. doi: 10.3389/fmed.2021.704256. PMID: 34660623; PMCID: PMC8514781.
    8. Vaishya R, Javaid M, Khan IH, Haleem A. Artificial Intelligence (AI) applications for COVID-19 pandemic. Diabetes Metab Syndr. 2020 Jul-Aug;14(4):337-339. doi: 10.1016/j.dsx.2020.04.012. Epub 2020 Apr 14. PMID: 32305024; PMCID: PMC7195043.
    9. Imad-Addin A. The power of artificial intelligence for improved patient outcomes, ethical practices, and overcoming challenges. IgMin Res. 2024;2:597-600.
    10. Qazi Waqas K. A machine learning-based method for COVID-19 and pneumonia detection. IgMin Res. 2024;2:518-23.
    11. Tajmirriahi M, Masjedi Esfahani M, Amouaghaei Z, Mansori N, Miralaei P, Lalehzar SS, Shirani P, Saadatnia M. Cardioembolic stroke, the most common subtype of stroke in COVID 19: A single center experience from Isfahan, Iran. J Res Med Sci. 2023 Feb 21;28:10. doi: 10.4103/jrms.jrms_594_21. PMID: 36974106; PMCID: PMC10039102.
    12. Zuin M, Mazzitelli M, Rigatelli G, Bilato C, Cattelan AM. Risk of ischemic stroke in patients recovered from COVID-19 infection: A systematic review and meta-analysis. Eur Stroke J. 2023 Dec;8(4):915-922. doi: 10.1177/23969873231190432. Epub 2023 Jul 25. PMID: 37491810; PMCID: PMC10372514.
    13. Ferrone SR, Sanmartin MX, Ohara J, Jimenez JC, Feizullayeva C, Lodato Z, Shahsavarani S, Lacher G, Demissie S, Vialet JM, White TG, Wang JJ, Katz JM, Sanelli PC. Acute ischemic stroke outcomes in patients with COVID-19: a systematic review and meta-analysis. J Neurointerv Surg. 2024 Mar 14;16(4):333-341. doi: 10.1136/jnis-2023-020489. PMID: 37460215.
    14. Libruder C, Hershkovitz Y, Ben-Yaish S, Tanne D, Keinan-Boker L, Binyaminy B. An Increased Risk for Ischemic Stroke in the Short-Term Period following COVID-19 Infection: A Nationwide Population-Based Study. Neuroepidemiology. 2023;57(4):253-259. doi: 10.1159/000531163. Epub 2023 Jul 3. PMID: 37399799; PMCID: PMC11251667.
    15. Anastasia V, Sergey S, Anastasia S, Tatyana V, Igor V. The model for clinical, laboratory, and genetic prediction of recurrent ischemic stroke against the background of laboratory aspirin resistance using machine learning. IgMin Res. 2024;2:39-44.
    16. Roman-Gonzalez A, Naranjo CA, Cardona-Maya WD, Vallejo D, Garcia F, Franco C, Alvarez L, Tobón LI, López MI, Rua C, Bedoya G, Cadavid Á, Torres JD. Frequency of Aspirin Resistance in Ischemic Stroke Patients and Healthy Controls from Colombia. Stroke Res Treat. 2021 May 21;2021:9924710. doi: 10.1155/2021/9924710. PMID: 34094500; PMCID: PMC8164531.
    17. Darya S, Ksenia F, Elizaveta S, Tatyana S, Yulia Z. Study of the histological features of the stroma of high-grade gliomas depending on the status of the mutation in the IDH1 gene. IgMin Res. 2024;2:702-8.
    18. Richardson TE, Hatanpaa KJ, Walker JM. Molecular Characterization of "True" Low-Grade IDH-Wildtype Astrocytomas. J Neuropathol Exp Neurol. 2021 Apr 16;80(5):431-435. doi: 10.1093/jnen/nlab023. PMID: 33829259.
    19. Álvarez-Torres MDM, López-Cerdán A, Andreu Z, de la Iglesia Vayá M, Fuster-Garcia E, García-García F, García-Gómez JM. Vascular differences between IDH-wildtype glioblastoma and astrocytoma IDH-mutant grade 4 at imaging and transcriptomic levels. NMR Biomed. 2023 Nov;36(11):e5004. doi: 10.1002/nbm.5004. Epub 2023 Jul 21. PMID: 37482922.
    20. Simion CI, Elena Violeta C, Costin George F, Teodora Elena T, Cosmin B, Anwar E, et al. Diagnostic challenges in pancreatic tumors. IgMin Res. 2024;2:348-53.
    21. González-Gómez R, Pazo-Cid RA, Sarría L, Morcillo MÁ, Schuhmacher AJ. Diagnosis of Pancreatic Ductal Adenocarcinoma by Immuno-Positron Emission Tomography. J Clin Med. 2021 Mar 10;10(6):1151. doi: 10.3390/jcm10061151. PMID: 33801810; PMCID: PMC8000738.
    22. Miura F, Takada T, Amano H, Yoshida M, Furui S, Takeshita K. Diagnosis of pancreatic cancer. HPB (Oxford). 2006;8(5):337-42. doi: 10.1080/13651820500540949. PMID: 18333085; PMCID: PMC2020745.
    23. González DG, Asensio DE, Pinto FP, Pérez SB, Pacheco SD. Peritoneal carcinomatosis from ovarian cancer: a case report. IgMin Res. 2024;2:309-12.
    24. Della Corte L, Conte C, Palumbo M, Guerra S, Colacurci D, Riemma G, De Franciscis P, Giampaolino P, Fagotti A, Bifulco G, Scambia G. Hyperthermic Intraperitoneal Chemotherapy (HIPEC): New Approaches and Controversies on the Treatment of Advanced Epithelial Ovarian Cancer-Systematic Review and Meta-Analysis. J Clin Med. 2023 Nov 9;12(22):7012. doi: 10.3390/jcm12227012. PMID: 38002626; PMCID: PMC10672052.
    25. van Driel WJ, Koole SN, Sikorska K, Schagen van Leeuwen JH, Schreuder HWR, Hermans RHM, de Hingh IHJT, van der Velden J, Arts HJ, Massuger LFAG, Aalbers AGJ, Verwaal VJ, Kieffer JM, Van de Vijver KK, van Tinteren H, Aaronson NK, Sonke GS. Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer. N Engl J Med. 2018 Jan 18;378(3):230-240. doi: 10.1056/NEJMoa1708618. PMID: 29342393.
    26. Fabrizio P, Daria C, Ugo P, Gabriella T, Luigi M. Preventing rectal toxicity in prostate cancer: diet and supplement alternative to enemas or rectal spacer. IgMin Res. 2024;2:171-6.
    27. Schaefer C, Zamboglou C, Volegova-Neher N, Martini C, Nicolay NH, Schmidt-Hegemann NS, Rogowski P, Li M, Belka C, Müller AC, Grosu AL, Brunner T. Impact of a low FODMAP diet on the amount of rectal gas and rectal volume during radiotherapy in patients with prostate cancer - a prospective pilot study. Radiat Oncol. 2020 Jan 30;15(1):27. doi: 10.1186/s13014-020-1474-y. PMID: 32000818; PMCID: PMC6993432.
    28. Valdagni R, Rancati T. Reducing rectal injury during external beam radiotherapy for prostate cancer. Nat Rev Urol. 2013 Jun;10(6):345-57. doi: 10.1038/nrurol.2013.96. Epub 2013 May 14. PMID: 23670182.
    29. Zaira G, Asia G. Breast cancer: the road to a personalized prevention. IgMin Res. 2024;2:163-70.
    30. Prades J, Remue E, van Hoof E, Borras JM. Is it worth reorganising cancer services on the basis of multidisciplinary teams (MDTs)? A systematic review of the objectives and organisation of MDTs and their impact on patient outcomes. Health Policy. 2015 Apr;119(4):464-74. doi: 10.1016/j.healthpol.2014.09.006. Epub 2014 Sep 18. PMID: 25271171.
    31. Capobianco AML, Gallucci G, Lapadula L, Dinardo G, La Torre G, Sisti N, Sisti LG. Impact of the Multidisciplinary Cancer Team on the Diagnostic and Therapeutic Care Pathway of Early Breast Cancer Patients and Perception of Team Members: The Experience of a Cancer Centre in Italy. Cancer Invest. 2024 Jan;42(1):12-20. doi: 10.1080/07357907.2023.2300442. Epub 2024 Jan 22. PMID: 38149612.
    32. Lyman GH, Baker J, Geradts J, Horton J, Kimmick G, Peppercorn J, Pruitt S, Scheri RP, Hwang ES. Multidisciplinary care of patients with early-stage breast cancer. Surg Oncol Clin N Am. 2013 Apr;22(2):299-317. doi: 10.1016/j.soc.2012.12.005. Epub 2013 Jan 3. PMID: 23453336.
    33. Kočo L, Weekenstroo HHA, Lambregts DMJ, Sedelaar JPM, Prokop M, Fütterer JJ, Mann RM. The Effects of Multidisciplinary Team Meetings on Clinical Practice for Colorectal, Lung, Prostate and Breast Cancer: A Systematic Review. Cancers (Basel). 2021 Aug 18;13(16):4159. doi: 10.3390/cancers13164159. PMID: 34439312; PMCID: PMC8394238.
    34. El Hamsas EY, Omaima B, Zineb S, Najat EA, Driss R. The antioxidant and antidepressant properties of dietary proteins derived from egg and bean extracts and their acute toxicity: a journey from nutrition to pharmacognosy. IgMin Res. 2023;1:032-42.
    35. Steingart AB, Cotterchio M. Do antidepressants cause, promote, or inhibit cancers? J Clin Epidemiol. 1995 Nov;48(11):1407-12. doi: 10.1016/0895-4356(95)00545-5. PMID: 7490604.
    36. Zhuang Y, Pang X, Qi Y, Zhang T, Cao G, Xue H, Xu Y, Xie S, Liu Y, Wang Y, Li Y, Xiong Y, Li Y, Shen H. The incidence risk of breast and gynecological cancer by antidepressant use: A systematic review and dose-response meta-analysis of epidemiological studies involving 160,727 patients. Front Oncol. 2022 Oct 14;12:939636. doi: 10.3389/fonc.2022.939636. PMID: 36425551; PMCID: PMC9680975.
    37. Abadi B, Shahsavani Y, Faramarzpour M, Rezaei N, Rahimi HR. Antidepressants with anti-tumor potential in treating glioblastoma: A narrative review. Fundam Clin Pharmacol. 2022 Feb;36(1):35-48. doi: 10.1111/fcp.12712. Epub 2021 Jul 29. PMID: 34212424.
    38. Luo M, Zhou L, Huang Z, Li B, Nice EC, Xu J, Huang C. Antioxidant Therapy in Cancer: Rationale and Progress. Antioxidants (Basel). 2022 Jun 8;11(6):1128. doi: 10.3390/antiox11061128. PMID: 35740025; PMCID: PMC9220137.
    39. Liao J, Li X, Gan Y, Han S, Rong P, Wang W, Li W, Zhou L. Artificial intelligence assists precision medicine in cancer treatment. Front Oncol. 2023 Jan 4;12:998222. doi: 10.3389/fonc.2022.998222. PMID: 36686757; PMCID: PMC9846804.
    40. Rezayi S, R Niakan Kalhori S, Saeedi S. Effectiveness of Artificial Intelligence for Personalized Medicine in Neoplasms: A Systematic Review. Biomed Res Int. 2022 Apr 7;2022:7842566. doi: 10.1155/2022/7842566. PMID: 35434134; PMCID: PMC9010213.
    41. Bhinder B, Gilvary C, Madhukar NS, Elemento O. Artificial Intelligence in Cancer Research and Precision Medicine. Cancer Discov. 2021 Apr;11(4):900-915. doi: 10.1158/2159-8290.CD-21-0090. PMID: 33811123; PMCID: PMC8034385.
    42. Ho D. Artificial intelligence in cancer therapy. Science. 2020 Feb 28;367(6481):982-983. doi: 10.1126/science.aaz3023. PMID: 32108102.
    43. Chen ZH, Lin L, Wu CF, Li CF, Xu RH, Sun Y. Artificial intelligence for assisting cancer diagnosis and treatment in the era of precision medicine. Cancer Commun (Lond). 2021 Nov;41(11):1100-1115. doi: 10.1002/cac2.12215. Epub 2021 Oct 6. PMID: 34613667; PMCID: PMC8626610.
    44. Cè M, Irmici G, Foschini C, Danesini GM, Falsitta LV, Serio ML, Fontana A, Martinenghi C, Oliva G, Cellina M. Artificial Intelligence in Brain Tumor Imaging: A Step toward Personalized Medicine. Curr Oncol. 2023 Feb 22;30(3):2673-2701. doi: 10.3390/curroncol30030203. PMID: 36975416; PMCID: PMC10047107.

Similar Articles

PUBLISH YOUR RESEARCH

We publish a wide range of article types in biology, medicine and engineering with no editorial biases.

Submit

See Manuscript Guidelines and APC

Explore the IgMin Subjects
Google Scholar
welcome Image

Google Scholar, beta-launched in November 2004, acts as an academic navigator through vast scholarly seas. It covers peer-reviewed journals, books, conference papers, theses, dissertations, preprints, abstracts, technical reports, court opinions, and patents. Search IgMin Articles